Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.

Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W, Jack C Jr, Weiner M, Davatzikos C, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative Investigators.

JAMA Neurol. 2015 May;72(5):571-81. doi: 10.1001/jamaneurol.2014.4829.

PMID:
25822737
2.

Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.

Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, Edland SD, Salmon DP, Galasko DR, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative Investigators.

JAMA Neurol. 2015 May;72(5):546-53. doi: 10.1001/jamaneurol.2014.4477.

3.

Sex modifies the APOE-related risk of developing Alzheimer disease.

Altmann A, Tian L, Henderson VW, Greicius MD; Alzheimer's Disease Neuroimaging Initiative Investigators.

Ann Neurol. 2014 Apr;75(4):563-73. doi: 10.1002/ana.24135. Epub 2014 Apr 14.

4.

Predicting brain activity using a Bayesian spatial model.

Derado G, Bowman FD, Zhang L; Alzheimer's Disease Neuroimaging Initiative Investigators.

Stat Methods Med Res. 2013 Aug;22(4):382-97. doi: 10.1177/0962280212448972. Epub 2012 Jun 28.

5.

Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search.

Stein JL, Hibar DP, Madsen SK, Khamis M, McMahon KL, de Zubicaray GI, Hansell NK, Montgomery GW, Martin NG, Wright MJ, Saykin AJ, Jack CR Jr, Weiner MW, Toga AW, Thompson PM; Alzheimer’s Disease Neuroimaging Initiative Investigators.

Mol Psychiatry. 2011 Sep;16(9):927-37, 881. doi: 10.1038/mp.2011.32. Epub 2011 Apr 19.

6.

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.

Schott JM, Bartlett JW, Fox NC, Barnes J; Alzheimer's Disease Neuroimaging Initiative Investigators.

Ann Neurol. 2010 Dec;68(6):825-34. doi: 10.1002/ana.22315.

PMID:
21181717
7.

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.

Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators.

Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. doi: 10.1016/j.neurobiolaging.2010.04.011.

Supplemental Content

Loading ...
Support Center